Article Details

Lessons from a biotech downturn: Funding challenges, an IPO dry spell and what to expect in 2024

Retrieved on: 2023-10-26 16:42:58

Tags for this article:

Click the tags to see associated articles and topics

Lessons from a biotech downturn: Funding challenges, an IPO dry spell and what to expect in 2024. View article details on HISWAI: https://www.biopharmadive.com/news/biotech-startup-financing-ipo-downturn-lessons/697855/

Excerpt

... BioPharma Dive reporter Gwendolyn Wu speaking with biotech executives and experts during an Oct. 25 panel. Edward Pagliarulo/BioPharma Dive.

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up